- All sections
- C - Chemistrymetallurgy
- C40B - Combinatorial chemistrylibraries, e.g. chemical libraries
- C40B 40/02 - Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cellsLibraries contained in or displayed by vectors, e.g. plasmidsLibraries containing only microorganisms or vectors
Patent holdings for IPC class C40B 40/02
Total number of patents in this class: 608
10-year publication summary
14
|
25
|
25
|
54
|
52
|
38
|
28
|
22
|
37
|
15
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 286 |
39 |
The Regents of the University of California | 20087 |
17 |
Massachusetts Institute of Technology | 10110 |
8 |
President and Fellows of Harvard College | 5998 |
8 |
Yale University | 2409 |
8 |
Genentech, Inc. | 4001 |
7 |
Adimab, LLC | 145 |
7 |
The Governing Council of The University of Toronto, | 1484 |
7 |
DuPont US Holding, LLC | 97 |
7 |
The Board of Trustees of the Leland Stanford Junior University | 6462 |
6 |
Affinity Biosciences Pty Ltd | 10 |
6 |
National Research Council of Canada | 1547 |
6 |
The University of British Columbia | 1509 |
6 |
48Hour Discovery Inc. | 9 |
6 |
Takeda Pharmaceutical Company Limited | 2706 |
5 |
Adaptimmune Limited | 182 |
5 |
CytomX Therapeutics, Inc. | 223 |
5 |
The Governors of the University of Alberta | 873 |
5 |
Immunocore Limited | 217 |
5 |
Nantbio, Inc. | 140 |
5 |
Other owners | 440 |